India holds the dubious distinction as the diabetes capital of the world. While there are many avenues to visit a doctor and consult a specialist, BeatO is one such platform that focuses exclusively on diabetes prevention, management, and reversal.
Describing how the platform came into being, Gautam Chopra, CEO and Co-founder, BeatO Health Arx Technologies says, “In 2015, I left my comfortable job as Head of Business Development and Sales Steering with Lufthansa in Europe to embark on my entrepreneurial journey. I started BeatO in 2015 with my Co-founder Yash Sehgal to become India’s largest app-based platform to prevent, control and reverse diabetes with over 1 million members.”
BeatO started as an app to log sugar levels, health stats, food and exercise. It has evolved into a full-stack digital app-based platform that provides clinically proven, comprehensive diabetes care programmes to help prevent, control and reverse the condition under the guidance of experts. The results of these programmes have been published in top medical institutions such as the American Diabetes Association, APCON and AATD.
The investors saw potential in this app and subsequently invested heavily. BeatO has raised its pre-series B funding round with W health ventures, Blume Ventures, Orios and Leo capital as its major investors. Today it has one million app users, 350,000 paid members with a 60 per cent Y1 retention, and clocking $12 million in annualised revenue run-rate.
“A big learning for me was to build our product by being close to our customers. We did this by meeting hundreds of people with diabetes, and deeply understanding their pain points. Secondly, whilst we had a great product, we needed to get it into lakhs of homes,” adds Chopra.